Gilead Sciences : GILD

All Gilead Sciences Articles

730 Articles

Douglas A. McIntyre | Jun 25, 2009 at 11:31 AM EDT

Generic Biotech Drug Approval in Japan, Implications in U.S. and Abroad (NVS, PFE, AZN, AMGN, GENZ, GILD, CELG)

Novartis AG (NYSE: NVS) shares are at session highs and well of the lows of the day in the early…

Douglas A. McIntyre | Apr 27, 2009 at 6:40 AM EDT

Swine Flu Lessons from SARS, Mad Cow & Bird Flu of Past (GILD, BCRX, NVAX, GNBT, VICL, AVII, CRXL, RHHBY, GSK, SFD, EWW, MXF)

Monday is looking like a SWINE FLU speculative flu stock stock bonanza, and we want to caution about some of…

Douglas A. McIntyre | Mar 12, 2009 at 8:10 AM EDT

Gilead Wins CV Therapeutics Bid; Higher Bid Coming? (GILD, CVTX)

Gilead Sciences, Inc. (Nasdaq: GILD) has agreed to buy CV Therapeutics, Inc. (Nasdaq: CVTX) for $20.00 per share in cash.

Douglas A. McIntyre | Feb 5, 2009 at 5:57 PM EST

Can Biogen Idec Earnings Generate A Buyout? (BIIB, AMGN, GILD, GENZ, CELG, MRK, SNY, GSK)

Biogen Idec Inc. (NASDAQ: BIIB) is set to report earnings on Friday morning. What many investors probably want to know…

Douglas A. McIntyre | Jan 5, 2009 at 7:15 AM EST

Is Pfizer About To Be On Acquisition Path? (PFE, AMGN, WYE, GILD, BMY, LLY, SGP, CELG, GENZ, BIIB)

There may be some speculation that drug giant Pfizer Inc. (NYSE: PFE) is looking at expansion through acquisitions. The FT…

Douglas A. McIntyre | Dec 23, 2008 at 7:38 AM EST

Top Analyst Upgrades & Downgrades (ACM, AXYS, CTAS, CVD, GILD, PPDI, VISN, EPG, VTIV)

It is getting pretty thin in major analyst coverage as firms are encouraged to go easy on major year-end calls…

Douglas A. McIntyre | Dec 15, 2008 at 7:52 AM EST

Top Pre-Market Analyst Upgrades (MO, BBY, CFL, CEPH, GILD, LMT, TNDM, NOC, TLAB, MTN)

These are the top pre-market upgrades and positive analyst calls we have seen from Wall Street this Monday morning: Altria…

Douglas A. McIntyre | Dec 10, 2008 at 11:04 AM EST

Short Sellers, No Direction in Biotech (AMGN, BIIB, CELG, GENZ, GILD)

It seems that short sellers have no real direction in the major NASDAQ biotech stocks from mid-November to late-November. Generally…

Douglas A. McIntyre | Oct 16, 2008 at 3:23 PM EDT

Gilead Boosted Partly By Currencies (GILD)

Gilead Sciences Inc. (NASDAQ: GILD) has just issued its third quarter earnings at $0.52 net EPS and $0.55 non-GAAP EPS…

Douglas A. McIntyre | Sep 17, 2008 at 8:03 AM EDT

Day Trader Alert: Gilead Sciences (GILD)

Gilead Sciences Inc. (NASDAQ: GILD) is trading down this morning. Goldman Sachs maintained its buy rating on the stock, but…

Douglas A. McIntyre | Sep 12, 2008 at 6:28 AM EDT

Top Pre-Market Analyst Upgrades (DBD, FFIV, FSLR, GILD, GHL, WM)

There are surprisingly few analyst calls today, but these are some of the top positive calls and upgrades with more…

Douglas A. McIntyre | Jul 18, 2008 at 6:46 AM EDT

Top Analyst Downgrades (BBY, KO, EBAY, GILD, IGT, MAC, SUN, TSO, VRTU)

These are not all of the Downgrades or negative analyst calls seen this morning but these are some of the…

Douglas A. McIntyre | Jun 19, 2008 at 6:11 AM EDT

Top 10 Pre-Market Analyst Calls (AIG, BARE, CWST, DNA, GILD, MHS, SLAB, TKLC, UBS, WCA)

These are ten of the analyst calls we are seeing early this Thursday morning in early bird pre-market trading hours:…

Douglas A. McIntyre | Apr 16, 2008 at 3:37 PM EDT

Gilead Sciences… The Beat Goes On (GILD)

Gilead Sciences, Inc. (NASDAQ: GILD) posted results after the close today. Its Q1 revenues surged to $1.26 billion and non-GAAP…

Douglas A. McIntyre | Apr 16, 2008 at 1:03 PM EDT

Picking Apart Gilead Ahead of Earnings (GILD)

After today’s close, we’ll get to see earnings out of Gilead Sciences Inc. (NASDAQ: GILD). The estimates for the biopharmaceutical…

1 … 46 47 48 49

Gilead Sciences : GILD

All Gilead Sciences Articles

Generic Biotech Drug Approval in Japan, Implications in U.S. and Abroad (NVS, PFE, AZN, AMGN, GENZ, GILD, CELG)

Swine Flu Lessons from SARS, Mad Cow & Bird Flu of Past (GILD, BCRX, NVAX, GNBT, VICL, AVII, CRXL, RHHBY, GSK, SFD, EWW, MXF)

Gilead Wins CV Therapeutics Bid; Higher Bid Coming? (GILD, CVTX)

Can Biogen Idec Earnings Generate A Buyout? (BIIB, AMGN, GILD, GENZ, CELG, MRK, SNY, GSK)

Is Pfizer About To Be On Acquisition Path? (PFE, AMGN, WYE, GILD, BMY, LLY, SGP, CELG, GENZ, BIIB)

Top Analyst Upgrades & Downgrades (ACM, AXYS, CTAS, CVD, GILD, PPDI, VISN, EPG, VTIV)

Top Pre-Market Analyst Upgrades (MO, BBY, CFL, CEPH, GILD, LMT, TNDM, NOC, TLAB, MTN)

Short Sellers, No Direction in Biotech (AMGN, BIIB, CELG, GENZ, GILD)

Gilead Boosted Partly By Currencies (GILD)

Day Trader Alert: Gilead Sciences (GILD)

Top Pre-Market Analyst Upgrades (DBD, FFIV, FSLR, GILD, GHL, WM)

Top Analyst Downgrades (BBY, KO, EBAY, GILD, IGT, MAC, SUN, TSO, VRTU)

Top 10 Pre-Market Analyst Calls (AIG, BARE, CWST, DNA, GILD, MHS, SLAB, TKLC, UBS, WCA)

Gilead Sciences… The Beat Goes On (GILD)

Picking Apart Gilead Ahead of Earnings (GILD)

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk

3 Reasons Retirees Should Not Enroll in Medicare Advantage for 2026

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

Gilead Sciences : GILD

All Gilead Sciences Articles

Generic Biotech Drug Approval in Japan, Implications in U.S. and Abroad (NVS, PFE, AZN, AMGN, GENZ, GILD, CELG)

Swine Flu Lessons from SARS, Mad Cow & Bird Flu of Past (GILD, BCRX, NVAX, GNBT, VICL, AVII, CRXL, RHHBY, GSK, SFD, EWW, MXF)

Gilead Wins CV Therapeutics Bid; Higher Bid Coming? (GILD, CVTX)

Can Biogen Idec Earnings Generate A Buyout? (BIIB, AMGN, GILD, GENZ, CELG, MRK, SNY, GSK)

Is Pfizer About To Be On Acquisition Path? (PFE, AMGN, WYE, GILD, BMY, LLY, SGP, CELG, GENZ, BIIB)

Top Analyst Upgrades & Downgrades (ACM, AXYS, CTAS, CVD, GILD, PPDI, VISN, EPG, VTIV)

Top Pre-Market Analyst Upgrades (MO, BBY, CFL, CEPH, GILD, LMT, TNDM, NOC, TLAB, MTN)

Short Sellers, No Direction in Biotech (AMGN, BIIB, CELG, GENZ, GILD)

Gilead Boosted Partly By Currencies (GILD)

Day Trader Alert: Gilead Sciences (GILD)

Top Pre-Market Analyst Upgrades (DBD, FFIV, FSLR, GILD, GHL, WM)

Top Analyst Downgrades (BBY, KO, EBAY, GILD, IGT, MAC, SUN, TSO, VRTU)

Top 10 Pre-Market Analyst Calls (AIG, BARE, CWST, DNA, GILD, MHS, SLAB, TKLC, UBS, WCA)

Gilead Sciences… The Beat Goes On (GILD)

Picking Apart Gilead Ahead of Earnings (GILD)

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

Featured Reads

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk

3 Reasons Retirees Should Not Enroll in Medicare Advantage for 2026